Skip to main content

Utilization of Biktarvy, Odefsey, Symtuza, and Genvoya: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
Biktarvy
Genvoya
Odefsey
Symtuza
Description

In this analysis, we evaluated trends in utilization of Biktarvy, Odefsey, Symtuza, and Genvoya in the Merative™ MarketScan® Research Databases.

The study period includes data from November 1, 2015 to June 30, 2023. This request was run against the Merative™ MarketScan® Research Databases on July 24, 2024.

Deliverables (1)
Sentinel Modular Program Report: Utilization of Biktarvy, Odefsey, Symtuza, and Genvoya: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
November 1, 2015 – June 30, 2023
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Merative™ MarketScan® Research Databases
Related Links
Sentinel Drug Study: Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) & Signal Identification